2 glaring issues for DX that I believe RAP needs to fix:
1) Tony is still talking about DX as an "ADD-ON":
DX is only available to Telehealth providers (Coviu and Phenix) as a 3rd party add-on is very disappointing.
Doctors are not going to download add-ons. I wouldn't want my GP using a 3rd party app to diagnose me either- I personally would not trust it.
DX needs to be integrated into the platforms and backed by the providers to offer training / education on its use.
2) Branding:
The current implementation does not instill confidence for consumers or doctors - If DX was branded as a clinically validated "virtual stethoscope" and integrated into an established platform (Healthdirect or Coviu) I think it would have far better uptake.
"Virtual stethoscope" works as both consumers and doctors will immediately understand what it's for and what gap it fills in a teleheath setting.
The Stethoscope has been a trusted clinical tool for almost 200 years and is still used in most respiratory consultations. Who would trust a doctor to diagnose their respiratory condition without using one.
Feel free to email these suggestions to Tony
- Forums
- ASX - By Stock
- RAP
- Ann: Quarterly Activities Report and Appendix 4C
Ann: Quarterly Activities Report and Appendix 4C, page-99
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)